Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

Medtronic (NYSE: MDT) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth ...

Medtronic is among the world’s largest makers of medical devices. - Jenn Ackerman for WSJ. Medical-device maker Medtronic ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, ...

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...

Ireland: Medtronic plc has announced its intent to separate its Diabetes business into a new standalone company.The ...